4//SEC Filing
Lingamneni Anila 4
Accession 0001127602-24-016816
CIK 0000313143other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:44 PM ET
Size
6.6 KB
Accession
0001127602-24-016816
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Award
Common Stock
2024-05-28+14,140→ 28,825 total - Tax Payment
Common Stock
2024-05-28$95.73/sh−5,279$505,359→ 23,546 total
Footnotes (3)
- [F1]Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024.
- [F2]This number includes unvested restricted stock units ("RSUs") previously reported.
- [F3]Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001808414
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 5:44 PM ET
- Size
- 6.6 KB